BioSim News

10

Apr 2025

Joint position on the draft law on medicines and medical devices

Apr 10 2025 Biosim

Blog post

08

Apr 2025

Joint statement on the draft law on medicines and health products

Apr 08 2025 Biosim

Blog post

11

December 2024

BioSim subscribes to the Pharmaceutical Industry Strategy, approved by the Council of Ministers

11 2024 December Biosim

Blog post

09

December 2024

The BioSim Ethics Commission presents its recommendations on the use of biosimilars

09 2024 December Biosim

Blog post

26

Meitheamh 2024

BioSim promotes training on the impact of biosimilars on sustainability and access

26 June 2024 Biosim

Blog post

26

Meitheamh 2024

The Ministry of Health will take advantage of upcoming regulatory projects to promote the biosimilar

26 June 2024 Biosim

Blog post

11

Meitheamh 2024

Biosimilars saved more than 1.800 billion to the health system in 2023

11 June 2024 Biosim

Blog post

08

Meitheamh 2024

Interviews Connect SEDISA with Encarnación Cruz

08 June 2024 Biosim

Blog post

08

Meitheamh 2024

SERMAS improves information on biosimilars to its healthcare professionals

08 June 2024 Biosim

Blog post

09

May 2024

Sustainability and access, axes of the development of the biosimilars market

09 May 2024 Biosim

Blog post

01

May 2024

Little biosimilar competition due to upcoming patent expirations

01 May 2024 Biosim

Blog post

21

Márta 2024

BioSim, in favor of the EMA considering a more specific regulation for biosimilars

March 21 2024 Biosim

Blog post

01

Márta 2024

Europe dedicated more than 8.000 million euros to the purchase of biosimilars

March 01 2024 Biosim

Blog post

20

February 2024

“The arrival of biosimilars advances treatment with a biological by 19 months”

Feb 20 2024 Biosim

Blog post

08

February 2024

BioSim, at #23CNF

Feb 08 2024 Biosim

Blog post

13

December 2023

Conference on biosimilars for ophthalmologists and pharmacists

13 2023 December Biosim

Blog post

27

November 2023

BioSim strategies so that biosimilars can continue providing sustainability to the market

November 27 2023 Biosim

Blog post

16

November 2023

BioSim asks the European Commission to integrate incentives for companies that manufacture biosimilars into the new community legislation

November 16 2023 Biosim

Blog post

26

October 2023

BioSim renews its Board of Directors and re-elects Joaquín Rodrigo as president

October 26 2023 Biosim

Blog post

17

October 2023

SEOM and BioSim agree to reinforce knowledge of biosimilars among oncology professionals and patients

October 17 2023 Biosim

Blog post

10

October 2023

Patients, training and new biosimilar scenarios, BioSim's lines of action for 2024

October 10 2023 Biosim

Blog post

02

October 2023

BioSim and SEFAP renew their collaboration agreement to improve training on biosimilar medicines

October 02 2023 Biosim

Blog post

30

Sep 2023

BioSim advocates improvement in the training of professionals and patients in the face of the arrival of new biosimilars

30 September 2023 Biosim

Blog post

23

Christmas

Health spending on biosimilars breaks record by exceeding 1.000 million euros

Jul 23 2023 Biosim

Blog post

11

Christmas

Biosimilars: the sector takes stock

Jul 11 2023 Biosim

Blog post

28

Meitheamh 2023

Biosimilars, an opportunity to advance the use of biologicals

28 June 2023 Biosim

Blog post

21

Meitheamh 2023

Innovation, regulation and competition. Biosimilar medicines and their incorporation into the clinic

21 June 2023 Biosim

Blog post

14

Meitheamh 2023

The Extremadura Health Service defends the use of biosimilar medicines to promote the sustainability of the health system

14 June 2023 Biosim

Blog post

12

Meitheamh 2023

The second season of video advice on biosimilars and pharmacy is here

12 June 2023 Biosim

Blog post

06

Meitheamh 2023

BioSim launches an informative video on Shared Profits with biosimilars

06 June 2023 Biosim

Blog post

29

May 2023

The biosimilar demands new spaces for clinical trials in Spanish hospitals

29 May 2023 Biosim

Blog post

19

May 2023

The commitment to biosimilar medicines translates into savings of more than 1.000 million euros annually

19 May 2023 Biosim

Blog post

16

May 2023

BioSim participates in the Conference "Biosimilars: value-based management"

16 May 2023 Biosim

Blog post

11

Apr 2023

The heads of Pharmacy of the Autonomous Communities highlight the training of health professionals, the collection and analysis of data and incentives as key drivers for the promotion of biosimilars

Apr 11 2023 Biosim

Blog post

10

Márta 2023

María Jesús Lamas: Biosimilar medicines are essential to modulate the pharmaceutical market

March 10 2023 Biosim

Blog post

09

Márta 2023

The WTO Training Foundation and BioSim organize the conference "Biosimilars: lessons learned and future challenges"

March 09 2023 Biosim

Blog post

02

Márta 2023

“Biosimilars favor innovation and its financing”

March 02 2023 Biosim

Blog post

28

February 2023

"The Law of Guarantees has to be reviewed in the concept of biosimilars"

Feb 28 2023 Biosim

Blog post

27

February 2023

Extremadura, the first autonomous community to launch a Profit Sharing Program for biosimilar medicines

Feb 27 2023 Biosim

Blog post

20

February 2023

Biosimilars save 1.000 million euros a year for the health system

Feb 20 2023 Biosim

Blog post

16

February 2023

The Spanish biosimilars industry defends a minimum profitability threshold to guarantee its contribution to the health system

Feb 16 2023 Biosim

Blog post

27

Jan 2023

BioSim transfers to the Ministry of Health its proposals to promote biosimilar medicines in the SNS

Jan 27 2023 Biosim

Blog post

01

December 2022

Doctors will have more training resources on biosimilar medicines

01 2022 December Biosim

Blog post

29

November 2022

BioSim's position on the new Reference Price Order

November 29 2022 Biosim

Blog post

07

November 2022

The biosimilar joins the request to diversify the price criteria

November 07 2022 Biosim

Blog post

05

October 2022

Agreement between the Andalusian School of Public Health and BioSim to analyze the national market for biosimilars

October 05 2022 Biosim

Blog post

04

October 2022

The Department of Health analyzes together with BioSim the opportunity of biosimilar medicines for a more effective management

October 04 2022 Biosim

Blog post

02

October 2022

Seizing the opportunity in the midst of the crisis

October 02 2022 Biosim

Blog post

20

Sep 2022

Biosimilar medicines in Primary Care

20 September 2022 Biosim

Blog post

20

Sep 2022

BioSim welcomes the EMA and HMA statement on the interchangeability of biosimilar medicines

20 September 2022 Biosim

Blog post

13

Sep 2022

Reasonable price and strategic priority, BioSim request for electro-intensive pharmaceutical industries

13 September 2022 Biosim

Blog post

09

Sep 2022

"The last 40 years have been a real boom in therapeutic terms"

09 September 2022 Biosim

Blog post

06

Christmas

BioSim supports the CNMC proposals for competition between biosimilar and original medicines

Jul 06 2022 Biosim

Blog post

01

Christmas

The OAFI Foundation, AECOSAR and BioSim committed to bringing knowledge of biosimilars closer to patients

Jul 01 2022 Biosim

Blog post

30

Meitheamh 2022

BioSim exposed the situation of biosimilar medicines in the SNS

30 June 2022 Biosim

Blog post

22

Meitheamh 2022

The CEU San Pablo University and BioSim come together to train students in biosimilars

22 June 2022 Biosim

Blog post

01

Meitheamh 2022

Agreement between SEFH and BioSim to disseminate the role of biosimilars

01 June 2022 Biosim

Blog post

26

May 2022

BioSim Agreement - General Nursing Council. Joint initiatives for more and better information and training of the nursing community in biosimilars

26 May 2022 Biosim

Blog post

23

May 2022

CGCOF. "Biosimilars and Pharmacy", a new thematic channel for video advice on YouTube

23 May 2022 Biosim

Blog post

19

May 2022

Collaboration agreement. The Spanish Society of Primary Care Pharmacists and BioSim, committed to promoting knowledge about biosimilars

19 May 2022 Biosim

Blog post

18

May 2022

BioSim's contributions in the prior consultation process of the new Industry law

18 May 2022 Biosim

Blog post

20

Apr 2022

BioSim, constituent association of the "Vanguard Health Alliance"

Apr 20 2022 Biosim

Blog post

04

Apr 2022

Biosimilars in the pharmacy: what can we improve?

Apr 04 2022 Biosim

Blog post

02

Apr 2022

Research and manufacturing of biosimilars in Spain must be encouraged to boost innovation and competition

Apr 02 2022 Biosim

Blog post

30

Márta 2022

"Transparency and benchmarking for the promotion of biosimilars"

March 30 2022 Biosim

Blog post

23

Márta 2022

Biosim adheres to the 'Science in Parliament' initiative

March 23 2022 Biosim

Blog post

10

Márta 2022

Shared profits; a new kind of career incentive

March 10 2022 Biosim

Blog post

02

Márta 2022

Generics and biosimilars demand specific regulations in their state plan

March 02 2022 Biosim

Blog post

28

February 2022

“Biosimilars allow to improve the treatment of patients and the health outcome”

Feb 28 2022 Biosim

Blog post

26

Jan 2022

Biosim gives adalimumab the highest estimated savings in biosimilars by 2022

Jan 26 2022 Biosim

Blog post

18

Jan 2022

Organon joins BioSim in a clear commitment to biosimilar medicines

Jan 18 2022 Biosim

Blog post

13

Jan 2022

BioSim considers that the INGESA specifications present some deficits in aspects that are "essential"

Jan 13 2022 Biosim

Blog post

09

December 2021

Universidad Europea and BioSim will promote knowledge of biosimilars among students

09 2021 December Biosim

Blog post

02

December 2021

Interview with Isabel del Río, deputy director of BioSim, in the magazine "Pharmaboardroom"

02 2021 December Biosim

Blog post

12

November 2021

BioSim exposes the situation of biosimilar medicines in Spain at the Festival of Biologics

November 12 2021 Biosim

Blog post

11

November 2021

BioSim and the General Council of Pharmacists promote knowledge of biosimilar medicines

November 11 2021 Biosim

Blog post

04

November 2021

Joaquín Rodrigo, re-elected for a fourth term as president of Biosim

November 04 2021 Biosim

Blog post

03

November 2021

BioSim joins the One Health initiative

November 03 2021 Biosim

Blog post

01

November 2021

BioSim statements in relation to the Generics and Biosimilars Plan

November 01 2021 Biosim

Blog post

27

October 2021

Biosim is committed to promoting training in biosimilars

October 27 2021 Biosim

Blog post

18

October 2021

Biosimilars in Spain: an exponential opportunity with adequate policies

October 18 2021 Biosim

Blog post

08

October 2021

The director of BioSim, at the Women of Health forum

October 08 2021 Biosim

Blog post

26

Sep 2021

Biosimilars: tools for an innovative and sustainable future

26 September 2021 Biosim

Blog post

16

Sep 2021

We participated in the debate on "Biosimilars: Optimizing the efficiency of our Health System"

16 September 2021 Biosim

Blog post

09

Sep 2021

BioSim meets with the General Council of Colleges of Pharmacists

09 September 2021 Biosim

Blog post

05

Christmas

Biosimilars: are we ready to face the next avalanche?

Jul 05 2021 Biosim

Blog post

30

Meitheamh 2021

The consumption of biosimilars in Primary Care increased by more than 300% compared to 2018

30 June 2021 Biosim

Blog post

17

Meitheamh 2021

The generic and biosimilar plan "requires incentives and value purchases"

17 June 2021 Biosim

Blog post

17

Meitheamh 2021

BioSim joins the IDIS manifesto for "better Health"

17 June 2021 Biosim

Blog post

15

Meitheamh 2021

The effects of biosimilars in rheumatoid arthritis

15 June 2021 Biosim

Blog post

08

Meitheamh 2021

BioSim launches a section on its website to disseminate knowledge about biosimilars among patients

08 June 2021 Biosim

Blog post

18

May 2021

The Pact for Science and Innovation grows

18 May 2021 Biosim

Blog post

29

Apr 2021

Biosim urges the EC to create a legislative framework favorable to biosimilars in European pharmaceutical legislation

Apr 29 2021 Biosim

Blog post

26

Márta 2021

Experts see it as "highly feasible" to implement profit-sharing programs with biosimilar drugs in Spain

March 26 2021 Biosim

Blog post

10

Márta 2021

BioSim and the Francisco de Vitoria University of Madrid train the health professionals of the future

March 10 2021 Biosim

Blog post

08

Márta 2021

Today we join the celebration of #DíaDeLaMujer

March 08 2021 Biosim

Blog post

02

Márta 2021

Biosim asks the CNMC for measures that allow biosimilars to "compete on a level playing field"

March 02 2021 Biosim

Blog post

22

February 2021

BioSim calculates the economic resources released by the use of biosimilar medicines in 930 at more than 2021 million euros

Feb 22 2021 Biosim

Blog post

15

February 2021

"We have fulfilled our role as promoter of biosimilars"

Feb 15 2021 Biosim

Blog post

26

Jan 2021

BioSim congratulates Carolina Darias and encourages her to "value the role of biosimilar medicines"

Jan 26 2021 Biosim

Blog post

05

Jan 2021

"To value the biosimilars revolution, pedagogical work is very important"

Jan 05 2021 Biosim

Blog post

30

November 2020

Biosim welcomes that the European Strategy "highlights the role of biosimilars" in accessibility

November 30 2020 Biosim

Blog post

27

November 2020

Clinical management, incentives and biosimilars

November 27 2020 Biosim

Blog post

27

November 2020

Budget impact analysis of biosimilar medicines in the Spanish National Health System (2009-2022)

November 27 2020 Biosim

Blog post

15

October 2020

AIReF's recognition of biosimilars: important support for the sector

October 15 2020 Biosim

Blog post

07

October 2020

For BioSim, Profarma could be a program that the Government integrates into the "National Recovery and Resilience Plan" that it has to present to the European Commission

October 07 2020 Biosim

Blog post

07

October 2020

Call for the SEFH-BioSim Awards

October 07 2020 Biosim

Blog post

07

October 2020

Encarnación Cruz: "We have an opportunity to streamline the authorization and commercialization processes of biosimilars"

October 07 2020 Biosim

Blog post

28

Sep 2020

"A fair price should help sustainability, but also give a benefit to the seller"

28 September 2020 Biosim

Blog post

28

Sep 2020

"I want to consolidate BioSim as a benchmark"

28 September 2020 Biosim

Blog post

22

Sep 2020

BioSim sends the European Commission its proposals to promote the use of biosimilar medicines in the context of the new Pharmaceutical Strategy for Europe

22 September 2020 Biosim

Blog post

11

Sep 2020

BioSim welcomes the public consultation on the Strategy of the European Network of Medicines Agencies for 2025

11 September 2020 Biosim

Blog post

30

Meitheamh 2020

BioSim notes the favorable reception that the parliamentary groups in the Commission for Reconstruction have given to the measures to promote biosimilar medicines

30 June 2020 Biosim

Blog post

19

Meitheamh 2020

Encarna Cruz, new CEO of BioSim

19 June 2020 Biosim

Blog post

22

Apr 2020

Our beloved Director General Regina Múzquiz Vicente-Arche has passed away

Apr 22 2020 Biosim

Blog post

02

Márta 2020

BioSim sees the need for a Strategic Plan for biosimilars in Spain

March 02 2020 Biosim

Blog post

07

February 2020

Biosimilars and SNS

Feb 07 2020 Biosim

Blog post

11

December 2019

2019: biosimilars in the spotlight

11 2019 December Biosim

Blog post

08

November 2019

Joaquín Rodrigo, re-elected as president of BioSim

November 08 2019 Biosim

Blog post

15

October 2019

Biosim and the General Council will promote the healthcare role of pharmacists in the dispensing of biosimilar medicines

October 15 2019 Biosim

Blog post

10

October 2019

The BioSim Advisory Council reinforces the proposals aimed at a more efficient use of biological therapies through biosimilars

October 10 2019 Biosim

Blog post

25

Sep 2019

SEFAC and SEMERGEN present with BioSim the first online course on biological, original and biosimilar medicines, aimed at community pharmacists and primary care physicians

25 September 2019 Biosim

Blog post

20

Sep 2019

Biosim: "Our claims are reflected in the reference prices"

20 September 2019 Biosim

Blog post

01

Christmas

BioSim participates in the IV Symposium "Oncopromesas vs. Oncosaurs” in Santander, which discussed the role of biosimilar drugs in cancer therapies Copia

Jul 01 2019 Biosim

Blog post

28

Meitheamh 2019

Biosimilar medicines: an opportunity for the national health system

28 June 2019 Biosim

Blog post

11

Meitheamh 2019

Regina Múzquiz: "The biosimilar is an incentive for research into new products"

11 June 2019 Biosim

Blog post

11

May 2019

Biosim values the plan to promote biosimilars, pending its consolidation

11 May 2019 Biosim

Blog post

25

February 2019

Experts highlight the role of the pharmacist in monitoring and adherence to biosimilar medicines

Feb 25 2019 Biosim

Blog post

21

February 2019

moving towards consensus

Feb 21 2019 Biosim

Blog post

08

Jan 2019

Improving knowledge about biosimilars increases their employment and builds trust

Jan 08 2019 Biosim

Blog post

20

December 2018

The BioSim Advisory Board confirms the high degree of consensus reached between healthcare professionals and patients regarding the use of biosimilar medicines

20 2018 December Biosim

Blog post

11

December 2018

BioSim and SEDISA establish a collaboration framework for the development of the opportunities that biosimilar medicines offer to the National Health System

11 2018 December Biosim

Blog post

19

October 2018

Valencia is committed to promoting biosimilars so that innovation penetrates at the lowest price

October 19 2018 Biosim

Blog post

05

October 2018

BioSim promotes with the Junta de Extremadura a conference on biosimilar medicines aimed at professionals from the Extremadura Health Service

October 05 2018 Biosim

Blog post

04

Meitheamh 2018

Biosimilars: efficacy, effectiveness and efficiency

04 June 2018 Biosim

Blog post

16

Apr 2018

Experts endorse the use of biosimilar medicines to maintain the sustainability of the health system and improve access to biological treatments

Apr 16 2018 Biosim

Blog post

21

Márta 2018

BioSim and FACME sign an agreement to improve knowledge about biosimilar medicines and share clinical experience

March 21 2018 Biosim

Blog post

26

February 2018

"Biosimilars must enter slowly but surely, not in a rush"

Feb 26 2018 Biosim

Blog post

09

February 2018

“We are more than open to signing a sustainability pact with the administration”

Feb 09 2018 Biosim

Blog post

26

Jan 2018

BioSim's contribution to the Health Pact

Jan 26 2018 Biosim

Blog post

21

December 2017

Biosim renews its Board of Directors and re-elects Joaquín Rodrigo as president of the Association

21 2017 December Biosim

Blog post

11

December 2017

Biosimilars: innovation, access, sustainability

11 2017 December Biosim

Blog post

05

December 2017

What do I need to know about Biosimilar Medicines - Information for patients

05 2017 December Biosim

Blog post

13

November 2017

Biosim and the Spanish Patient Forum start a collaboration model aimed at improving knowledge of biosimilar medicines

November 13 2017 Biosim

Blog post

28

Sep 2017

The WTO and BIOSIM will jointly offer training programs on biosimilars for doctors

28 September 2017 Biosim

Blog post

06

Christmas

BioSim expands its Advisory Council and advances the implementation of the Biosimilar Medicines Observatory

Jul 06 2017 Biosim

Blog post

04

Christmas

Biosim presents the "Guide to Biosimilars for Physicians"

Jul 04 2017 Biosim

Blog post

20

Meitheamh 2017

Biosimilars: new ways to innovate

20 June 2017 Biosim

Blog post

08

Meitheamh 2017

The biopharmaceutical Amgen joins the Spanish Association of Biosimilars

08 June 2017 Biosim

Blog post

19

May 2017

"We advocate a framework agreement model without subsequent negotiation in hospitals"

19 May 2017 Biosim

Blog post

20

Apr 2017

BioSim participates in the Meeting on Health organized by Unidad Editorial

Apr 20 2017 Biosim

Blog post

19

Apr 2017

BioSim meets with the Secretary of State for R+D+i

Apr 19 2017 Biosim

Blog post

07

Apr 2017

BioSim visits the mAbxience biosimilar production facility

Apr 07 2017 Biosim

Blog post

05

Apr 2017

Biosim, constituent association of the Biomedical Industries Forum

Apr 05 2017 Biosim

Blog post

05

Apr 2017

Biosim attends the congress "Biosimilar Medicines: a game changer for sustainability in health" organized by the association "Medicines for Europe"

Apr 05 2017 Biosim

Blog post

08

February 2017

The Minister of Health, Social Services and Equality receives the Spanish Association of Biosimilars Biosim

Feb 08 2017 Biosim

Blog post

22

November 2016

The Spanish Association of Biosimilar Medicines, BioSim, inaugurates its new offices

November 22 2016 Biosim

Blog post

06

Sep 2016

Regina Múzquiz, General Director of BioSim

06 September 2016 Biosim

Blog post

16

Meitheamh 2016

BioSim constitutes its Advisory Council made up of professionals and patients

16 June 2016 Biosim

Blog post

03

November 2015

BioSim is born to represent the entire biosimilars industry in Spain

November 03 2015 Biosim

Blog post